Royal Bank Of Canada Armata Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.4 - $3.9 $360 - $585	150 Added 576.92%	176 $0
Q1 2024 Nov 05, 2024	SELL	$2.81 - $4.18 $421 - $627	-150 Reduced 85.23%	26 $0
Q1 2024 May 15, 2024	SELL	$2.81 - $4.18 $719 - $1,070	-256 Reduced 90.78%	26 $0
Q4 2023 Feb 14, 2024	BUY	$1.95 - $3.24 $514 - $855	264 Added 1466.67%	282 $0
Q2 2023 Aug 14, 2023	BUY	$1.14 - $1.7 $20 - $30	18 New	18 $0
Q3 2022 Nov 14, 2022	BUY	$3.12 - $4.92 $283 - $447	91 Added 211.63%	134 $1,000
Q3 2021 Nov 15, 2021	SELL	$3.55 - $4.14 $7 - $8	-2 Reduced 4.44%	43 $0
Q2 2021 Aug 16, 2021	BUY	$3.89 - $4.87 $175 - $219	45 New	45 $0

1.38M

400

17.3K

Ticker ARMP
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,144,700
Market Cap $70.1M
Description
Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.